Background: Fecal incontinence (FI) is a prevalent but poorly recognized problem in the general population with profound negative effects on daily life. The prevalence of FI in irritable bowel syndrome (IBS) and its association with clinical, demographic, and pathophysiological factors remain largely unknown.
| INTRODUCTION
Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders (FGIDs) with a pooled world-wide prevalence of 11% in existing studies, 1 but with large differences in prevalence figures due to methodological variance and heterogeneity between studies. 2 Irritable bowel syndrome is defined by the Rome criteria and is characterized by a combination of abdominal pain or discomfort and abnormal bowel habits. 3 Apart from the characteristic IBS symptoms included in the diagnostic criteria, many patients with IBS also suffer from other troublesome symptoms and syndromes, including other FGIDs, non-gastrointestinal symptoms and psychiatric comorbid disorders. [4] [5] [6] Among FGIDs, especially the overlap with functional dyspepsia is well documented, [7] [8] [9] whereas the overlap with other conditions with disturbed gastrointestinal (GI) function is less well-studied. Despite being a benign condition from a medical point of view, quality of life is substantially reduced in IBS patients, 10, 11 and comorbid GI and non-GI conditions adds further to the disease burden and quality of life impairment.
12
Fecal incontinence (FI), defined as unintentional loss of solid or liquid stool, 13 is a common but often neglected problem in the population.
Prevalence estimates for community-dwelling subjects range from 7%
to 15%, with discrepancies between studies partly being explained by differences in survey methods, age range of included subjects, and definitions of FI. 13 In several studies increasing age, burden of general illness, rectal urgency, and diarrhea have been identified as risk factors for FI. [14] [15] [16] [17] When FI is frequent or associated with larger amounts of stool loss, it can have a profound negative impact on quality of life, [18] [19] [20] and often leads to embarrassment, isolation, reduced scope of life activities such as travel or social events, and psychological distress.
Moreover, only a minority of individuals with FI discuss this problem with their physician, leaving the problem unaddressed and untreated for many of those who suffer substantial adverse consequences. [21] [22] [23] In population-based studies IBS has been found to be a risk factor for FI. 14, 15 However, despite the fact that these two prevalent conditions constitute a substantial burden of the workload for gastroenterologists and GI surgeons, and lead to high costs for society, 1, 2, 13, 24, 25 surprisingly few studies have assessed the overlap between IBS and FI.
Moreover, factors associated with coexistence of the conditions and their combined additive effect on the overall disease burden are incompletely understood. In the existing studies that have evaluated the prevalence of FI in patients with IBS, the rates differ substantially, ranging from 6.2% to 57%. 21, 26, 27 These seemingly discrepant results are likely in part attributable to differences in patient selection, definition of FI and screening questions. These studies have also yielded mixed results regarding the association between FI in IBS, IBS symptom severity, demographic factors, health care seeking, psychological factors, bowel habits, and quality of life. 21, 26, 27 Moreover, none of these studies have evaluated the association with key pathophysiological factors in IBS, such as visceral hypersensitivity and GI motor abnormalities. [28] [29] [30] [31] [32] Therefore, in this study we used two large, well-characterized cohorts of IBS patients from two western countries with different healthcare systems but comparable prevalence of IBS and FI 
| MATERIALS AND METHODS

| Subjects
We included subjects with IBS according to the Rome III criteria, 3 who participated in two prospective studies assessing the relevance of pathophysiological factors for symptoms in IBS. 28, [35] [36] [37] [38] The patients in the first of these study cohorts were recruited from the outpatient clinic specialized in functional GI disorders at Sahlgrenska University Hospital in Gothenburg, Sweden. severe psychiatric disease; a history of drug or alcohol abuse within 6 months prior to enrollment; or pregnancy at the time of the study.
The second cohort was patients in a research clinic specialized in functional GI disorders at the University of North Carolina in Chapel Hill, USA. The patients were 18 years or older (no upper limit), and were recruited by advertisements or physician referrals and screened by telephone before inclusion. They met the Rome III criteria for IBS, and had been diagnosed with IBS by a physician before enrollment, which was confirmed by means of an interview and examination conducted by a gastroenterologist. Exclusion criteria were: other GI disease(s) explaining the patient's symptoms, including GI resection (other than appendectomy or cholecystectomy), known inflammatory bowel disease, celiac disease, lactose malabsorption; heart disease; diabetes mellitus; or pregnancy at the time of the study.
All patients in both study cohorts were given study-specific verbal and written information before giving their written consent to participate in the studies. The Regional Ethical Review Board in Gothenburg, and the Institutional Review Board of the University of North Carolina, respectively, approved the study prior to the start of patient enrollment.
| Study measures
| Questionnaires
Demographics
Basic demographic information about participants was obtained by a study nurse/research coordinator at both sites, using standardized case
Key Points
• Fecal incontinence is prevalent in the general population and has profound negative effects on daily life. Few studies have assessed the overlap between IBS and fecal incontinence.
• Fecal incontinence was reported by 14 to 20% of IBS patients, and it was associated with loose, frequent stools, urgency, and adverse impact on quality of life, psychological symptoms, and work productivity.
• Clinicians managing patients with IBS should include questions about fecal incontinence when taking the clinical history since this may guide management and improve clinical outcomes.
report forms. Of these variables, age, gender, height, and weight (for calculation of body mass index) were used in the analyses in this study.
GI symptoms
The severity of IBS symptoms was evaluated at both sites with the widely used and validated questionnaire, IBS Severity Scoring System (IBS-SSS). 39 This questionnaire is based on five items; frequency and severity of abdominal pain, severity of abdominal distension, bowel habit dissatisfaction and interference of IBS with daily life. The questionnaire uses visual analog scales and each item is scored 0-100, which yields a total score ranging from 0 to 500, with higher scores reflecting more severe symptoms. According to validated cut-off levels, the patients were divided into IBS severity groups of mild IBS (score of <175), moderate IBS (175-300), or severe IBS (>300).
The patients also completed the Rome III diagnostic questionnaire for the adult functional GI disorders. 40 For this study, we included select questions from this questionnaire with three purposes: (i) Questions in the IBS module to verify that the patients fulfilled the Rome III criteria for IBS; (ii) Questions to characterize the presence and type of FI/accidental bowel leakage in the last 3 months: frequency (never -less than one day a month -one day a month -two to three days a month -one day a week -more than one day a week -every day), amount (small -moderate -large), and composition of leakage (liquid/mucus onlystool only -both liquid/mucus and stool); and (iii) Questions to characterize the bowel habit of the patient: frequent (≥4/day) or infrequent (<3/week) bowel movements, hard or lumpy stools, loose or watery stools, and urgency (have to rush to the toilet to have a bowel movement) (response alternatives for all these questions: never or rarelysometimes -often -most of the time -always). The information about the frequency of hard and lumpy stools, and loose and watery stools was also used for subgrouping of the IBS patients with the response of "sometimes" being used as the cut-off level (this is the appropriate equivalent of 25% of the time according to the Rome III committee).
3,40
Disease-specificqualityoflife 43 Each of these subscales consist of six items asking how much the patients were bothered by each of the symptoms, on a 0-4 scale ranging from
"not bothered at all" to "extremely bothered". The sum scores of the subscales were transformed to standardized scores, where the mean for the healthy population is 50 and each standard deviation is 10 (T scores). The standardized scores also adjust for gender differences.
Workproductivityandactivity
This was only measured in the Swedish sample by using the Work
Productivity and Activity Index -irritable bowel syndrome version (WPAI:IBS)
. 44 This questionnaire consists of six questions, and from these four metrics can be derived: absenteeism (the percentage of work time missed due to IBS in the past 7 days), presenteeism (the percentage of impairment suffered while at work due to IBS in the past 7 days), overall work impairment (the total percentage of missed time due to IBS-related absenteeism or presenteeism in the past 7 days), and activity impairment (the percentage of impairment suffered due to IBS during daily activities in the past 7 days). Each metric varies from 0% to 100%, with higher scores indicating greater impairment.
| Physiologic measures
Colorectalsensitivity
Balloon distensions using an electronic barostat (Dual Drive Barostat, Distender Series II; G&J Electronics Inc, Toronto, ON, Canada) were performed at both sites to assess colorectal sensitivity. The Swedish patients underwent a rectal barostat study using an ascending methods of limits ramp distension protocol starting at 0 mm Hg and increasing in steps of 4 mm Hg every minute up to the pain threshold or to a maximum balloon pressure of 60 mm Hg. Thresholds for first sensation, urgency, discomfort and pain were assessed. 45 In the US patients, a colonic barostat test (where the test balloon was placed in the sigmoid colon with fluoroscopy guidance) was performed in the earliest of the consecutive patients (n=68), whereas the remainder underwent a rectal barostat study. 28 Both tests used an ascending methods of limits paradigm with phasic distensions of 30 seconds duration separated by 30 seconds rest intervals with the balloon at the operating pressure (i.e., the minimum pressure needed for inflating the balloon). The distensions started 2 mm Hg above the operating pressure and increased progressively in 2 mm Hg steps until the subject reported pain of moderate intensity (3 on a 0-4 scale) or until a balloon pressure of 48 mm Hg was reached. Thresholds for defecatory urge and pain were determined. To be able to combine the thresholds from the colonic and rectal barostat studies in the US sample, Z-scores (defining how many standard deviations a value is from the mean) were calculated. For the analyses in this study only the urge and pain thresholds from both the Swedish and US cohorts were used. Furthermore, as a measure of smooth muscle tone in the US cohort, average balloon volume at the operating pressure was analyzed (Z-scores), 28 and in the Swedish cohort the balloon pressure at half of the maximum observed volume (P 1/2 ) was used as a measure of compliance. 45 
Colorectalmotility
The Swedish patients underwent a colonic transit time measurement by ingesting 10 radiopaque markers per day during six consecutive days, and on the morning of the seventh day the remaining markers were counted using fluoroscopy (Exposcop 7000 Compact;
Ziemh GmbH, Nüremberg, Germany). 30 The colonic transit time 
| Data analysis
Statistical analyses were performed with the software package IBM SPSS Statistics version 22 (IBM Corporation, Armonk, NY, USA).
Data are presented as mean±SD and proportions (%). As a first step we analyzed the proportion of IBS subjects who reported accidental bowel leakage with different frequencies, the amount leaked and the composition of the bowel leakage. 
| RESULTS
| Subjects
We included 168 IBS patients fulfilling the Rome III criteria 3 in the Swedish cohort and 304 Rome III positive IBS patients in the US cohort. Demographic and disease related information for the two cohorts is displayed in Table 1 . As can be seen, the gender distribution and the mean age were comparable between cohorts, but the age range was wider in the US cohort as only subjects aged 18-65 years were included in the Swedish cohort. The patients in the Swedish cohort had more severe IBS symptoms and slightly lower BMI than the US patients, but the distribution of IBS subtypes based on the Rome III diagnostic questionnaire was similar in both cohorts with a clear predominance of patients with IBS-M. In the Swedish cohort all patients were Caucasian, whereas the US cohort was 68.5%
Caucasian, 28.1% African American, 1.3% Asian, and 2.0% American Indian/Alaska natives.
| Fecal incontinence in IBS
As can be seen in Fig. 1 Fig. 4 . In the Swedish cohort work productivity and activity measures of the WPAI:IBS showed greater impairment in patients with FI (Fig. 5) ; this information was not available in the US cohort.
| Fecal incontinence and other GI symptoms in IBS
| Fecal incontinence and psychological distress, quality of life and work productivity in IBS
| Fecal incontinence and colorectal physiology in IBS
In both cohorts patients underwent barostat tests to evaluate colorectal sensitivity (Table 2 ). There were no differences in urge or pain thresholds between patients with vs without FI in either sample. In the US cohort we also measured colorectal phasic motility response to stimuli and found no differences between patients with and without FI. Moreover, smooth muscle tone (US cohort) and compliance (Swedish patients) were similar in both patient groups (Table 2) . The bars show the proportion of subjects reporting a specific frequency of a bowel habit characteristics who also report fecal incontinence (accidental bowel leakage at least one day a month).
Colonic transit time was measured in the Swedish IBS patients and it
did not differ between patients with and without FI.
| Factors independently associated with fecal incontinence
Factors univariately associated with reporting FI (accidental bowel leakage ≥ one day a month) were thereafter entered into binary logistic regression models in the two cohorts (US cohort: age; body mass index; IBS severity (IBS-SSS); frequent stools, loose stools, and urgency (Rome III questionnaire). 
| DISCUSSION
In this study we have demonstrated that a substantial proportion, 14-20%, of Swedish and US IBS patients, who predominantly seek health care for their IBS symptoms, also suffer from FI, which appears higher than the rates typically reported in general population samples. 17, 33, 34 Moreover, we found that FI adds to the burden of IBS, with significant adverse impact seen on quality of life, psychological symptoms, and work productivity. The risk factors for FI in both US and Swedish patients with IBS were similar to those reported for the general population. [14] [15] [16] [17] One of the problems when comparing FI prevalence between studies is the use of different definitions and different questionnaires.
In our study, both cohorts used the same questionnaire, Rome III diagnostic questionnaire for the adult functional GI disorders, 40 and FI was defined as accidental bowel leakage at least once per month, a definition that has been used in a recent US national survey 17 and also fits with the current definition of FGIDs. 3, 40, 46, 47 The prevalence of FI using this definition differed between the cohorts, with a somewhat higher prevalence in US patients with IBS. This is hard to explain with the existing data, but a wider age range in the US cohort with more older subjects may be one explanation. Even though prevalence of FI was associated with IBS symptom severity, differences in prevalence rates between the cohorts cannot be explained by more severe IBS symptoms in the US cohort because the pattern was the opposite. Differences in health care systems, health care seeking behavior and willingness to participate in studies may have influenced our results, since our data are not population-based, but rather collected from IBS patients who were willing to participate in research studies on IBS pathophysiology. When our prevalence rates are compared with relevant studies of general population samples of equivalent age, the prevalence of FI appears higher than can be expected for a random population sample. In the US sample, the 19.7% rate of FI in our IBS patients was more than double the 8.3% rate reported in a nation-wide U.S. population survey of 4,308 individuals that used the same definition of FI, i.e. accidental bowel leakage at least one day a month. 17 Although, slightly different definitions and questions were used in a Swedish population-based survey, the FI rates in the Swedish IBS patients in the present study also appear higher than in the general population. 34 From a clinical point of view it seems highly relevant that one in every five to six IBS patients accidentally leaks stool each month, and if a less strict definition is used (also including accidental bowel leakage less than one day a month in the last 3 months), three to four out of every ten patients have FI. Based on the authors' experiences, these high prevalence rates are likely unknown to many clinicians managing IBS patients.
The few existing studies that have addressed the prevalence of FI in IBS have reported broadly varied prevalence rates. 21, 26, 27 In our study, we found that 14-20% of our IBS patients reported accidental bowel leakage at least one day a month in the last 3 months.
This seems very different from the prevalence rate of FI of 57% in a large clinical IBS sample in the study by Atarodi and colleagues. 21 However, in that study patients with accidental bowel leakage less than once a year were included in their definition of FI, and 24% of those had mild ("once a year or less"), 35% had moderate ("once a month or less but more than once a year"), and 32% had severe FI ("once a week or more or nocturnal"). Therefore, these findings are actually not so different from the findings in the present study, where we used a more stringent minimal frequency definition for identifying FI cases (i.e., at least once in the last month). The other two studies that have addressed the overlap between IBS and FI found that 18-23% of patients with IBS in a health maintenance organization, 27 and 6-20% of subjects with "bowel dysfunction compatible with IBS" in a survey of students reported that they "ever lost control of their bowels (including soiling of underwear)". 26 These studies are also difficult to compare directly with our findings, as the age range of subjects, the study settings, and incontinence definitions are very different.
Perhaps of even greater importance than the prevalence rates per se, is the finding that coexistence of IBS and FI negatively influence quality of life, and work productivity and activity, i.e. the presence of FI seem to potentiate the already substantial disease burden in IBS. Work productivity and activity is reduced in IBS patients, 48, 49 which leads to high costs for society 50 and reduced quality of life for patients. 48 In our Swedish sample, we used the validated WPAI:IBS questionnaire to assess work productivity and activity 44 and could demonstrate increased impairment in all four outcome measures with this questionnaire (absenteeism, presenteeism, overall work impairment, and activity impairment) in patients who had both IBS and FI.
Moreover, although there is no mortality or medically severe complications associated with IBS, the quality of life in IBS patients is reduced to the same extent as in many other chronic conditions associated with severe morbidity and mortality. 10 In both our IBS cohorts, the presence of FI was associated with even greater impairment in quality of life. These findings are in agreement with a study on patients with FI where the presence of IBS was found to substantially impair quality of life, 51 and also consistent with several other studies demonstrating that FI is associated with reduced quality of life. 18, 19 Regarding the association with psychological symptoms, there were differences between our cohorts. In the Swedish cohort, patients with FI and IBS 
